Robin Jeffrey Green

Title: Robin Jeffrey Green: Innovator in Antigen Binding Molecules

Introduction

Robin Jeffrey Green is a notable inventor based in Jamaica Plain, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of antigen binding molecules targeting SARS-CoV-2. With a total of 2 patents, his work is crucial in the ongoing fight against viral infections.

Latest Patents

One of his latest patents is focused on antigen binding molecules that specifically bind to the Spike glycoprotein of the severe acute respiratory syndrome coronavirus (SARS-CoV-2). This invention provides various embodiments, including polypeptides that can effectively target the virus. Additionally, it encompasses fusion proteins comprising these polypeptides, polynucleotides encoding them, vectors, and host cells suitable for expressing the polypeptides. The methods outlined in this patent aim to treat viral infections, including COVID-19.

Career Highlights

Robin Jeffrey Green is associated with Flagship Pioneering Innovations Vi, LLC, where he continues to push the boundaries of innovation in biotechnology. His work has garnered attention for its potential impact on public health and safety.

Collaborations

Some of his notable coworkers include Cheuk Lun Leung and Ross Steven Federman, who contribute to the collaborative efforts in their research and development projects.

Conclusion

Robin Jeffrey Green stands out as an influential inventor in the field of antigen binding molecules, with his work playing a vital role in addressing the challenges posed by viral infections. His contributions are essential in advancing medical science and improving health outcomes.